title: Uptake and metabolism of T-2 toxin in relation to its cytotoxicity in lymphoid cells.
abstract: The sensitivity of lymphoid cells to the cytotoxic effects of T-2 toxin (T-2) varies according to their degree of differentiation. To understand the mechanisms of these variations, the uptake and the metabolism of T-2 in susceptible (human lymphoma Daudi and phytohaemagglutinin-stimulated murine lymphocytes) and resistant (human leukaemia KE37 and REH) cells were studied in culture. When cells were incubated with [3H]T-2 a significant increase in the quantity of T-2 associated with the cell occurred during the first 30 min, this increased further from 10-16 hr, and decreased after 24 hr. Daudi and REH cells took up 20 and 3% of the T-2 present in the medium, respectively. Metabolites, extracted from the culture medium and from cells, were analysed by the thin-layer chromatography. The products were identified by comparison with standards for T-2 tetraol, T-2 triol, HT-2 toxin, neosolaniol and T-2. Qualitatively, similar metabolic pathways were found in all cells examined. The presence of these metabolites demonstrated that T-2 was taken up by these cells. A correlation existed between the relative sensitivities of the cells toward T-2 and the amount of intracellular T-2 and/or metabolites. It is thought that differences in the kinetics of uptake and processing of T-2 account for the known differences in cellular sensitivities to the toxin.
authors.affiliation: Laboratoire de Pathologie Cellulaire, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France.
authors.forename: J M
authors.initials: JM
authors.lastname: Porcher
authors.forename: C
authors.initials: C
authors.lastname: Dahel
authors.forename: C
authors.initials: C
authors.lastname: Lafarge-Frayssinet
authors.forename: F S
authors.initials: FS
authors.lastname: Chu
authors.forename: C
authors.initials: C
authors.lastname: Frayssinet
mesh_terms: D002478:Cells, Cultured; D002855:Chromatography, Thin Layer; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D012717:Sesquiterpenes / Q000378:metabolism*; D012995:Solubility; D013154:Spleen / Q000378:metabolism; D013605:T-2 Toxin / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology; D013997:Time Factors
chemical_list: D012717:Sesquiterpenes; D013605:T-2 Toxin